These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 23582448)

  • 21. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J
    Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of alkenylboronic acids as neuroprotective agents affecting multiple biological targets involved in Alzheimer's disease.
    Jiménez-Aligaga K; Bermejo-Bescós P; Martín-Aragón S; Csákÿ AG
    Bioorg Med Chem Lett; 2013 Jan; 23(2):426-9. PubMed ID: 23219701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
    Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
    J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
    Doggui S; Brouillette J; Chabot JG; Farso M; Quirion R
    Neurodegener Dis; 2010; 7(1-3):88-95. PubMed ID: 20173334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer's disease.
    Roy KK; Tota S; Tripathi T; Chander S; Nath C; Saxena AK
    Bioorg Med Chem; 2012 Nov; 20(21):6313-20. PubMed ID: 23026084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of intracellular Ca
    Goldberg J; Currais A; Ates G; Huang L; Shokhirev M; Maher P; Schubert D
    NPJ Aging Mech Dis; 2020; 6():10. PubMed ID: 32884834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aromatic amines and hydrazines drug acetylation, and lupus erythematodes.
    Reidenberg MM; Drayer DE
    Hum Genet Suppl; 1978; (1):57-63. PubMed ID: 285033
    [No Abstract]   [Full Text] [Related]  

  • 29. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2020 Mar; 15(3):269-271. PubMed ID: 31592694
    [No Abstract]   [Full Text] [Related]  

  • 30. Maleic hydrazide, a chemical mutagen in Drosophila melanogaster.
    Nasrat GE
    Nature; 1965 Jul; 207(995):439. PubMed ID: 5887300
    [No Abstract]   [Full Text] [Related]  

  • 31. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice.
    Prior M; Dargusch R; Ehren JL; Chiruta C; Schubert D
    Alzheimers Res Ther; 2013; 5(3):25. PubMed ID: 23673233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive multiomics approach toward understanding the relationship between aging and dementia.
    Currais A; Goldberg J; Farrokhi C; Chang M; Prior M; Dargusch R; Daugherty D; Armando A; Quehenberger O; Maher P; Schubert D
    Aging (Albany NY); 2015 Nov; 7(11):937-55. PubMed ID: 26564964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current evidence for J147 as a potential therapeutic agent in nervous system disease: a narrative review.
    Qiu F; Wang Y; Du Y; Zeng C; Liu Y; Pan H; Ke C
    BMC Neurol; 2023 Sep; 23(1):317. PubMed ID: 37674139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Small Molecule Positive Allosteric Modulator SPAM1 Triggers the Nuclear Translocation of PAC1-R to Exert Neuroprotective Effects through Neuron-Restrictive Silencer Factor.
    Fan G; Chen S; Liang L; Zhang H; Yu R
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. J147 Reduces tPA-Induced Brain Hemorrhage in Acute Experimental Stroke in Rats.
    Jin R; Wang M; Zhong W; Kissinger CR; Villafranca JE; Li G
    Front Neurol; 2022; 13():821082. PubMed ID: 35309561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Potent Multi-functional Neuroprotective Derivative of Tetramethylpyrazine.
    Chen HY; Xu DP; Tan GL; Cai W; Zhang GX; Cui W; Wang JZ; Long C; Sun YW; Yu P; Tsim KW; Zhang ZJ; Han YF; Wang YQ
    J Mol Neurosci; 2015 Aug; 56(4):977-987. PubMed ID: 25982925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. J-147 a Novel Hydrazide Lead Compound to Treat Neurodegeneration: CeeTox
    Lapchak PA; Bombien R; Rajput PS
    J Neurol Neurophysiol; 2013 Aug; 4(3):. PubMed ID: 25364619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Back to the future with phenotypic screening.
    Prior M; Chiruta C; Currais A; Goldberg J; Ramsey J; Dargusch R; Maher PA; Schubert D
    ACS Chem Neurosci; 2014 Jul; 5(7):503-13. PubMed ID: 24902068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of a potent neuroprotective hydrazide.
    Chiruta C; Zhao Y; Tang F; Wang T; Schubert D
    Bioorg Med Chem; 2013 May; 21(10):2733-41. PubMed ID: 23582448
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.